Beating earnings estimates typically has a positive impact on a company's stock price in the short term as it indicates better financial health and performance than analysts expected. For ProMIS Neurosciences, reporting a smaller loss than anticipated suggests operational efficiency or higher revenues, which can positively influence investor sentiment and potentially lead to a short-term increase in stock price.